Brett Collinge

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

Journal: Blood advances

Published: February 13, 2026

HNRNPU Mutations Redirect Cell Cycle Control to E2F in MYC-Driven Lymphomas.

HNRNPU Mutations Redirect Cell Cycle Control to E2F in MYC-Driven Lymphomas.

Journal: Blood advances

Published: November 25, 2025

HNRNPU mutations redirect cell cycle control to E2F in MYC-driven lymphomas.

HNRNPU mutations redirect cell cycle control to E2F in MYC-driven lymphomas.

Journal: Blood advances

Published: November 25, 2025

Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.

Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.

Journal: The American journal of surgical pathology

Published: October 28, 2025

Genomic Taxonomy of Aggressive B-Cell Lymphoid Neoplasms.

Genomic Taxonomy of Aggressive B-Cell Lymphoid Neoplasms.

Journal: Annual review of pathology

Published: October 16, 2025

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Journal: Blood advances

Published: May 28, 2025

Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.

Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.

Journal: Cancer immunology research

Published: April 04, 2025

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Journal: medRxiv : the preprint server for health sciences

Published: March 31, 2025

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Journal: Blood advances

Published: March 26, 2025

CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.

CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.

Journal: Blood

Published: June 11, 2024

Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.

Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.

Journal: Blood

Published: June 03, 2024

Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).

Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).

Journal: Blood

Published: February 09, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026